Co-Authors
This is a "connection" page, showing publications co-authored by Idris Guessous and Silvia Stringhini.
Connection Strength
4.348
-
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland. Nat Commun. 2021 06 08; 12(1):3455.
Score: 0.950
-
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020 08 01; 396(10247):313-319.
Score: 0.887
-
The Shift From Heart Disease to Cancer as the Leading Cause of Death in High-Income Countries: A Social Epidemiology Perspective. Ann Intern Med. 2018 12 18; 169(12):877-878.
Score: 0.795
-
Detection of Spatiotemporal Clusters of COVID-19-Associated Symptoms and Prevention Using a Participatory Surveillance App: Protocol for the @choum Study. JMIR Res Protoc. 2021 Oct 06; 10(10):e30444.
Score: 0.243
-
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak. Lancet Infect Dis. 2021 05; 21(5):600-601.
Score: 0.232
-
Socioeconomically Disadvantaged Neighborhoods Face Increased Persistence of SARS-CoV-2 Clusters. Front Public Health. 2020; 8:626090.
Score: 0.232
-
Geospatial digital monitoring of COVID-19 cases at high spatiotemporal resolution. Lancet Digit Health. 2020 08; 2(8):e393-e394.
Score: 0.222
-
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1. Eur J Clin Invest. 2021 Nov; 51(11):e13661.
Score: 0.060
-
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clin Microbiol Infect. 2021 Nov; 27(11):1695.e7-1695.e12.
Score: 0.060
-
Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic. Prev Med. 2021 09; 150:106696.
Score: 0.060
-
Insights into household transmission of SARS-CoV-2 from a population-based serological survey. Nat Commun. 2021 06 15; 12(1):3643.
Score: 0.059
-
Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study. Clin Infect Dis. 2021 May 27.
Score: 0.059
-
Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence Settings. J Clin Med. 2021 Apr 10; 10(8).
Score: 0.059
-
Perceptions of immunity and vaccination certificates among the general population: a nested study within a serosurvey of anti-SARS-CoV-2 antibodies (SEROCoV-POP). Swiss Med Wkly. 2020 11 16; 150:w20398.
Score: 0.057
-
Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland. Int J Public Health. 2020 Dec; 65(9):1529-1548.
Score: 0.057
-
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test. Eur J Clin Invest. 2020 Oct; 50(10):e13357.
Score: 0.056
-
Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests. J Clin Med. 2020 Jul 24; 9(8).
Score: 0.056
-
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect Dis. 2021 04; 21(4):e69-e70.
Score: 0.056
-
Life Course Socioeconomic Conditions and Frailty at Older Ages. J Gerontol B Psychol Sci Soc Sci. 2020 06 02; 75(6):1348-1357.
Score: 0.055
-
Association of early- and adult-life socioeconomic circumstances with muscle strength in older age. Age Ageing. 2018 May 01; 47(3):398-407.
Score: 0.048
-
Effect of Early- and Adult-Life Socioeconomic Circumstances on Physical Inactivity. Med Sci Sports Exerc. 2018 03; 50(3):476-485.
Score: 0.047